These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15569119

  • 21. [Burden of illness in Polish patients with reflux disease].
    Reguła J, Kulich KR, Stasiewicz J, Jasiński B, Carlsson J, Wiklund I.
    Przegl Epidemiol; 2005; 59(1):75-85. PubMed ID: 16013413
    [Abstract] [Full Text] [Related]

  • 22. Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.
    Nocon M, Labenz J, Jaspersen D, Leodolter A, Richter K, Vieth M, Lind T, Malfertheiner P, Willich SN.
    Aliment Pharmacol Ther; 2009 Mar 15; 29(6):662-8. PubMed ID: 19183146
    [Abstract] [Full Text] [Related]

  • 23. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity.
    Dubois RW, Aguilar D, Fass R, Orr WC, Elfant AB, Dean BB, Harper AS, Yu HT, Melmed GY, Lynn R, Singh A, Tedeschi M.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):487-500. PubMed ID: 17270005
    [Abstract] [Full Text] [Related]

  • 24. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.
    Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H.
    Aliment Pharmacol Ther; 2004 Oct 15; 20(8):891-8. PubMed ID: 15479361
    [Abstract] [Full Text] [Related]

  • 25. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments.
    Talley NJ, Fullerton S, Junghard O, Wiklund I.
    Am J Gastroenterol; 2001 Jul 15; 96(7):1998-2004. PubMed ID: 11467624
    [Abstract] [Full Text] [Related]

  • 26. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community.
    Wiklund I, Carlsson J, Vakil N.
    Am J Gastroenterol; 2006 Jan 15; 101(1):18-28. PubMed ID: 16405529
    [Abstract] [Full Text] [Related]

  • 27. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T.
    Aliment Pharmacol Ther; 2005 Jun 15; 21 Suppl 2():10-8. PubMed ID: 15943841
    [Abstract] [Full Text] [Related]

  • 28. Comparison between subjective and objective assessment of the long-term results after the Heller-Dor operation in patients affected by oesophageal achalasia.
    Mattioli S, Ruffato A, Di Simone MP, Lugaresi ML, D'Ovidio F.
    Dig Liver Dis; 2006 Aug 15; 38(8):544-51. PubMed ID: 16569523
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
    Aanen MC, Weusten BL, Numans ME, de Wit NJ, Baron A, Smout AJ.
    Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1377-84. PubMed ID: 17059519
    [Abstract] [Full Text] [Related]

  • 30. Review article: quality-of-life issues in gastro-oesophageal reflux disease.
    Quigley EM, Hungin AP.
    Aliment Pharmacol Ther; 2005 Aug 01; 22 Suppl 1():41-7. PubMed ID: 16042658
    [Abstract] [Full Text] [Related]

  • 31. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD, Kaufman JM, Sand PK, Smith N, Andoh M.
    Clin Ther; 2006 Nov 01; 28(11):1935-46. PubMed ID: 17213014
    [Abstract] [Full Text] [Related]

  • 32. Night-time and daytime atypical manifestations of gastro-oesophageal reflux disease: frequency, severity and impact on health-related quality of life.
    Dean BB, Aguilar D, Johnson LF, McGuigan JE, Orr WC, Fass R, Yan N, Morgenstern D, Dubois RW.
    Aliment Pharmacol Ther; 2008 Feb 15; 27(4):327-37. PubMed ID: 18005248
    [Abstract] [Full Text] [Related]

  • 33. ReQuest-- the challenge of quantifying both esophageal and extra-esophageal manifestations of GERD.
    Stanghellini V.
    Best Pract Res Clin Gastroenterol; 2004 Feb 15; 18 Suppl():27-30. PubMed ID: 15588792
    [Abstract] [Full Text] [Related]

  • 34. Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study.
    Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H.
    BMC Complement Altern Med; 2007 Apr 23; 7():10. PubMed ID: 17451595
    [Abstract] [Full Text] [Related]

  • 35. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
    Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):55-63. PubMed ID: 16803603
    [Abstract] [Full Text] [Related]

  • 36. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study.
    Haque M, Wyeth JW, Stace NH, Talley NJ, Green R.
    N Z Med J; 2000 May 26; 113(1110):178-81. PubMed ID: 10917077
    [Abstract] [Full Text] [Related]

  • 37. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
    Jaspersen D, Labenz J, Willich SN, Kulig M, Nocon M, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Stolte M, Malfertheiner P.
    Dig Liver Dis; 2006 Apr 26; 38(4):233-8. PubMed ID: 16413233
    [Abstract] [Full Text] [Related]

  • 38. The effect of Helicobacter pylori eradication on dyspeptic symptoms, acid reflux and quality of life in patients with functional dyspepsia.
    Bektas M, Soykan I, Altan M, Alkan M, Ozden A.
    Eur J Intern Med; 2009 Jul 26; 20(4):419-23. PubMed ID: 19524187
    [Abstract] [Full Text] [Related]

  • 39. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.
    Bretagne JF, Honnorat C, Richard-Molard B, Caekaert A, Barthélemy P.
    Aliment Pharmacol Ther; 2006 Mar 01; 23(5):607-16. PubMed ID: 16480400
    [Abstract] [Full Text] [Related]

  • 40. Functional heartburn vs. non-erosive reflux disease: similarities and differences.
    Hershcovici T, Zimmerman J.
    Aliment Pharmacol Ther; 2008 Jun 01; 27(11):1103-9. PubMed ID: 18315589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.